SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-003415
Filing Date
2015-09-09
Accepted
2015-09-09 16:29:40
Documents
10
Period of Report
2015-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q peregrine_10q-073115.htm 10-Q 327991
2 CERTIFICATION peregrine_ex3101.htm EX-31.1 7814
3 CERTIFICATION peregrine_ex3102.htm EX-31.2 7697
4 CERTIFICATION peregrine_ex32.htm EX-32 5298
  Complete submission text file 0001019687-15-003415.txt   2224832

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pphm-20150731.xml EX-101.INS 388606
6 XBRL SCHEMA FILE pphm-20150731.xsd EX-101.SCH 24899
7 XBRL CALCULATION FILE pphm-20150731_cal.xml EX-101.CAL 46607
8 XBRL DEFINITION FILE pphm-20150731_def.xml EX-101.DEF 55975
9 XBRL LABEL FILE pphm-20150731_lab.xml EX-101.LAB 174941
10 XBRL PRESENTATION FILE pphm-20150731_pre.xml EX-101.PRE 143392
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 151099162
SIC: 2834 Pharmaceutical Preparations